| # | Drug | Count |
|---|---|---|
| 0 | FLUOROURACIL | 10 |
| 1 | FLUOROURACIL CREAM, 0.5% | 10 |
| 2 | OXALIPLATIN | 10 |
| 3 | BEVACIZUMAB | 7 |
| 4 | CARBOPLATIN | 6 |
| 5 | ASPIRIN | 5 |
| 6 | ASPIRIN 325 MG | 5 |
| 7 | ASPIRIN 81 MG | 5 |
| 8 | PACLITAXEL | 5 |
| 9 | DEXAMETHASONE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIOGLITAZONE HYDROCHLORIDE | 1 | 0.0008 |
| 1 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0006 |
| 2 | OSPEMIFENE | 1 | 0.0004 |
| 3 | PONATINIB HYDROCHLORIDE | 2 | 0.0004 |
| 4 | REMDESIVIR | 3 | 0.0002 |
| 5 | HUMAN IMMUNOGLOBULIN G | 4 | 0.0002 |
| 6 | BISMUTH SUBSALICYLATE | 1 | 0.0002 |
| 7 | OXALIPLATIN | 10 | 0.0001 |
| 8 | ELTROMBOPAG OLAMINE | 3 | 0.0001 |
| 9 | FLUOROURACIL CREAM, 0.5% | 10 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 1 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 2 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 3 | 0.0002 |
| 3 | Bismuth [EPC] | 1 | 0.0002 |
| 4 | Antimalarial [EPC] | 1 | 0.0001 |
| 5 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 6 | Platinum-based Drug [EPC] | 19 | 0.0001 |
| 7 | Central Nervous System Stimulant [EPC] | 4 | 0.0000 |
| 8 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 12 | 0.0000 |